Experimental radiation drug enters first human tests for tough thyroid cancers
Disease control
Recruiting now
This is the first study in people testing a new drug called Af-001 for advanced thyroid cancer that has returned or spread after surgery and standard treatments. The first part checks the safety and best dose of a single injection. The second part tests multiple injections to see…
Phase: PHASE1 • Sponsor: Alpha Fusion Inc. • Aim: Disease control
Last updated Apr 23, 2026 12:43 UTC